These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 21196624)

  • 21. [Desensitization to rifampicin. Apropos of a case].
    Alonso MD; de la Hoz B; Cuevas M; Beick A
    Med Clin (Barc); 1996 Mar; 106(8):319. PubMed ID: 8667695
    [No Abstract]   [Full Text] [Related]  

  • 22. [Oral ulcers in kidney allograft recipients treated with sirolimus].
    Fricain JC; Cellerié K; Sibaud V; Catros S; Taïeb A; Merville P
    Ann Dermatol Venereol; 2008 Nov; 135(11):737-41. PubMed ID: 19061651
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinical aspects of rifampicin-associated pseudomembranous colitis.
    Jung SW; Jeon SW; Do BH; Kim SG; Ha SS; Cho CM; Tak WY; Kweon YO; Kim SK; Choi YH; Cha SI
    J Clin Gastroenterol; 2007 Jan; 41(1):38-40. PubMed ID: 17198063
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Thrombocytopenia--a rare but serious side effect of rifampicin.
    Shah NM; Venkatachalam S; Mehta Y; Balakrishnan C; Dubey SG; Mangat GK; Joshi VR
    J Assoc Physicians India; 1996 May; 44(5):359-60. PubMed ID: 9282598
    [No Abstract]   [Full Text] [Related]  

  • 25. Renal allograft dysfunction associated with rifampin-tacrolimus interaction.
    Chenhsu RY; Loong CC; Chou MH; Lin MF; Yang WC
    Ann Pharmacother; 2000 Jan; 34(1):27-31. PubMed ID: 10669182
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mycobacterium xenopi pulmonary infection in two renal transplant recipients under sirolimus therapy.
    Thaunat O; Morelon E; Stern M; Buffet P; Offredo C; Mamzer-Bruneel MF; Kreis H
    Transpl Infect Dis; 2004 Dec; 6(4):179-82. PubMed ID: 15762936
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Management of rifamycins-everolimus drug-drug interactions in a liver-transplant patient with pulmonary tuberculosis.
    Lefeuvre S; Rebaudet S; Billaud EM; Wyplosz B
    Transpl Int; 2012 Nov; 25(11):e120-3. PubMed ID: 22994607
    [No Abstract]   [Full Text] [Related]  

  • 28. Median effect analysis of efficacy versus adverse effects of immunosuppressants.
    Kahan BD; Kramer WG
    Clin Pharmacol Ther; 2001 Jul; 70(1):74-81. PubMed ID: 11452247
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Sirolimus-induced intractable chronic diarrhea: a case report.
    Alkhatib AA
    Transplant Proc; 2006 Jun; 38(5):1298-300. PubMed ID: 16797287
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Considerations in sirolimus use in the early and late post-transplant periods.
    Patel SJ; Elliott EN; Knight RJ; Gaber LW; Gaber AO
    Expert Opin Drug Saf; 2009 Jul; 8(4):421-34. PubMed ID: 19522662
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Rifampicin induced thrombocytopenia.
    Prasad R; Kant S; Pandey DK
    J Assoc Physicians India; 1999 Feb; 47(2):252. PubMed ID: 10999108
    [No Abstract]   [Full Text] [Related]  

  • 32. Sirolimus-induced hyperlipidaemia in liver transplant recipients is not dose-dependent.
    Firpi RJ; Tran TT; Flores P; Nissen N; Colquhoun S; Shackleton C; Martin P; Vierling JM; Poordad FF
    Aliment Pharmacol Ther; 2004 May; 19(9):1033-9. PubMed ID: 15113371
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Sympathetic dystrophy associated with sirolimus therapy.
    Molina MG; Diekmann F; Burgos D; Cabello M; Lopez V; Oppenheimer F; Navarro A; Campistol J
    Transplantation; 2008 Jan; 85(2):290-2. PubMed ID: 18212635
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Use of rifabutin for the treatment of a latent tuberculosis infection in a patient after solid organ transplantation.
    Hickey MD; Quan DJ; Chin-Hong PV; Roberts JP
    Liver Transpl; 2013 Apr; 19(4):457-61. PubMed ID: 23526600
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Acute rifampicin-induced adrenal insufficiency].
    Lorente R; Ampudia-Blasco FJ; Catalá M; Carmena R
    Rev Clin Esp; 1997 Oct; 197(10):725-6. PubMed ID: 9424678
    [No Abstract]   [Full Text] [Related]  

  • 36. Rifampicin-induced thrombocytopenia.
    Krishnappriya R
    J Assoc Physicians India; 2009 Mar; 57():213. PubMed ID: 19588650
    [No Abstract]   [Full Text] [Related]  

  • 37. Renal function improves in liver transplant recipients when switched from a calcineurin inhibitor to sirolimus.
    Fairbanks KD; Eustace JA; Fine D; Thuluvath PJ
    Liver Transpl; 2003 Oct; 9(10):1079-85. PubMed ID: 14526403
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A significant drug-drug interaction detected through corneal examination: resolution of cornea verticillata while using amiodarone.
    Mehta S; Bunya VY; Orlin SE; Sulewski ME; Dunaief JL
    Cornea; 2012 Jan; 31(1):81-3. PubMed ID: 21941175
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Significant sirolimus and dronedarone interaction in a kidney transplant recipient.
    Tichy EM; Medwid AJ; Mills EA; Formica RN; Kulkarni S
    Ann Pharmacother; 2010; 44(7-8):1338-41. PubMed ID: 20484171
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Impact of variability of sirolimus trough level on chronic allograft nephropathy.
    Wu MJ; Shu KH; Lian JD; Yang CR; Cheng CH; Chen CH
    Transplant Proc; 2008 Sep; 40(7):2202-5. PubMed ID: 18790192
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.